<?xml version="1.0" encoding="UTF-8"?>
<ref id="B25">
 <label>25.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Kam</surname>
    <given-names>Y-W</given-names>
   </name>
   <name>
    <surname>Lum</surname>
    <given-names>F</given-names>
   </name>
   <name>
    <surname>Teo</surname>
    <given-names>T</given-names>
   </name>
   <name>
    <surname>Lee</surname>
    <given-names>WW</given-names>
   </name>
   <name>
    <surname>Simarmata</surname>
    <given-names>D</given-names>
   </name>
   <name>
    <surname>Harjanto</surname>
    <given-names>S</given-names>
   </name>
   <etal/>
  </person-group>. 
  <article-title>Early neutralizing IgG response to chikungunya virus in infected patients targets a dominant linear epitope on the E2 glycoprotein</article-title>. 
  <source>EMBO Mol Med</source>. (
  <year>2012</year>) 
  <volume>4</volume>:
  <fpage>330</fpage>â€“
  <lpage>43</lpage>. 
  <pub-id pub-id-type="doi">10.1002/emmm.201200213</pub-id>
  <?supplied-pmid 22389221?>
  <pub-id pub-id-type="pmid">22389221</pub-id>
 </mixed-citation>
</ref>
